Vertex Pharma (VRTX) Tops Q3 EPS by 39c; Raises Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 551.15 +2.11 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $549.04 | 52 Week High | $134.71 | |||
| Open | $554.88 | 52 Week Low | $73.31 | |||
| Day High | $557.85 | P/E | N/A | |||
| Day Low | $547.56 | EPS | $-1.98 | |||
| Volume | 42,530 | |||||
